Advanced Medical Solutions Group (LSE:AMS) has published its Annual Report and Accounts for the year ended 31 December 2025 and confirmed that the documents, together with the notice for its forthcoming Annual General Meeting, have been distributed to shareholders. The AGM is scheduled to take place in London on 17 June 2026.
Company highlights governance focus and integration progress
All associated shareholder materials, including proxy voting forms and the formal meeting notice, have also been made available through the company’s website, reflecting AMS’s continued focus on shareholder engagement and corporate governance transparency.
The group said it continues to benefit from its scalable and diversified operating model, while integration work following the acquisition of Peters Surgical is contributing operational and commercial synergies. Surgical products now account for the majority of overall group revenue, with a growing share of sales being generated through direct sales channels.
Management believes these developments position the company for continued long-term growth and value creation, supported by expanding international operations and increasing commercial scale.
AMS’s broader outlook remains influenced by mixed financial factors, including improving revenue and cash flow trends alongside weaker profitability compared with earlier peak periods and higher leverage levels. Technical trading indicators remain supportive due to a strong longer-term share price trend, although momentum measures appear stretched. Valuation metrics continue to weigh on sentiment, reflecting a relatively high price-to-earnings ratio and a modest dividend yield.
More about Advanced Medical Solutions
Advanced Medical Solutions Group is a UK-based medical technology company focused on tissue-healing solutions, including surgical adhesives, sealants, biosurgical products and sutures. The business combines advanced material science with specialised applicator technologies to develop differentiated medical devices and has been expanding its international presence, particularly in the United States, following the acquisition of Peters Surgical.
Leave a Reply